Find the Perfect Plan for Your Investment Journey
O
Latest price
52 Week Range
CA$0.67 - CA$2.08
Next Earnings Date
May 07 2025
Next Earnings Date
May 07 2025
Latest price
Market Cap | CA$68.41M |
EV | CA$53.54M |
Shares Outstanding | 86.60M |
Beta | 1.55 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | CA$4.69 |
P/E 2025E | - |
P/Revenue 2025E | 61.02x |
Revenue | - |
EPS | 5.80% |
Operating Cash Flow | -6.30% |
Free Cash Flow | -6.20% |
Revenue | - |
EPS | 2.50% |
Operating Cash Flow | -16.90% |
Free Cash Flow | -20.90% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -189.05% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
O
Oncolytics Biotech Inc.
ONC
Sector
Healthcare
Industry
Biotechnology
CEO
Pisano, Wayne
Employees
28
Website
www.oncolyticsbiotech.comIPO Date
2000-06-01
Headquarters
322 11th Avenue SW, Suite 804, Calgary, Alberta, T2R 0C5, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved